Indivior PLC
LSE:INDV

Watchlist Manager
Indivior PLC Logo
Indivior PLC
LSE:INDV
Watchlist
Price: 802 GBX 1.52%
Market Cap: 1B GBX
Have any thoughts about
Indivior PLC?
Write Note

Indivior PLC
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Indivior PLC
Cash & Cash Equivalents Peer Comparison

Comparables:
GSK
AZN
VRNA
HIK
DPH

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Indivior PLC
LSE:INDV
Cash & Cash Equivalents
$302m
CAGR 3-Years
-33%
CAGR 5-Years
-21%
CAGR 10-Years
39%
GlaxoSmithKline PLC
LSE:GSK
Cash & Cash Equivalents
ÂŁ3B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Cash & Cash Equivalents
$6.9B
CAGR 3-Years
-24%
CAGR 5-Years
5%
CAGR 10-Years
3%
Verona Pharma PLC
NASDAQ:VRNA
Cash & Cash Equivalents
$336m
CAGR 3-Years
26%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Cash & Cash Equivalents
$133m
CAGR 3-Years
-18%
CAGR 5-Years
-16%
CAGR 10-Years
-7%
Dechra Pharmaceuticals PLC
LSE:DPH
Cash & Cash Equivalents
ÂŁ74.4m
CAGR 3-Years
-31%
CAGR 5-Years
-1%
CAGR 10-Years
9%

See Also

What is Indivior PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
302m USD

Based on the financial report for Jun 30, 2024, Indivior PLC's Cash & Cash Equivalents amounts to 302m USD.

What is Indivior PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
39%

Over the last year, the Cash & Cash Equivalents growth was -49%. The average annual Cash & Cash Equivalents growth rates for Indivior PLC have been -33% over the past three years , -21% over the past five years , and 39% over the past ten years .

Back to Top